BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,370,000 | -53.9% | 101,674 | -55.6% | 0.02% | -53.8% |
| Q2 2022 | $33,331,000 | +3583.0% | 228,747 | +2897.6% | 0.04% | +3800.0% |
| Q1 2022 | $905,000 | -87.1% | 7,631 | -85.0% | 0.00% | -83.3% |
| Q4 2021 | $7,029,000 | -58.1% | 51,007 | -57.7% | 0.01% | -60.0% |
| Q3 2021 | $16,768,000 | +259.4% | 120,710 | +151.2% | 0.02% | +275.0% |
| Q2 2021 | $4,665,000 | -50.7% | 48,054 | -65.3% | 0.00% | -55.6% |
| Q1 2021 | $9,455,000 | -45.2% | 138,335 | -31.3% | 0.01% | -43.8% |
| Q4 2020 | $17,263,000 | +20.8% | 201,409 | -8.4% | 0.02% | +6.7% |
| Q3 2020 | $14,295,000 | +19.3% | 219,897 | +34.1% | 0.02% | +7.1% |
| Q2 2020 | $11,985,000 | +96.9% | 163,940 | -8.4% | 0.01% | +55.6% |
| Q1 2020 | $6,088,000 | -36.6% | 178,897 | +1.5% | 0.01% | -10.0% |
| Q4 2019 | $9,596,000 | +2.1% | 176,265 | -21.7% | 0.01% | -16.7% |
| Q3 2019 | $9,398,000 | -19.6% | 225,254 | -15.6% | 0.01% | -20.0% |
| Q2 2019 | $11,688,000 | +481.8% | 266,916 | +583.8% | 0.02% | +400.0% |
| Q1 2019 | $2,009,000 | – | 39,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |